Elisabeth Wik

Cancer statistics, 2022

Cancer statistics, 2023

Childhood Guillain-Barré Syndrome: Clinical and Electrophysiologic Features Predictive of Outcome

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Triple-negative breast cancer molecular subtyping and treatment progress

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

Cancer statistics, 2020

Cancer Statistics, 2021

Contribution of central and peripheral factors to residual fatigue in Guillain–Barré syndrome

Endometrial Stromal Sarcomas

Guillain-Barré syndrome

Trends in GPCR drug discovery: new agents, targets and indications

The biology and function of fibroblasts in cancer

Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets

Current and future perspectives of liquid biopsies in genomics-driven oncology

Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice

Fc receptors for immunoglobulin G—a role in the pathogenesis of Guillain–Barré syndrome and multiple sclerosis

Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents

Long-term impact on work and private life after Guillain–Barré syndrome

IgG4-related disease

Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy

Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity

Interleukin-10 promoter polymorphisms in patients with Guillain–Barré syndrome

Guillain-Barré syndrome

Residual neuropathy in long-term population-based follow-up of Guillain–Barre syndrome

PD-1 deficiency reveals various tissue-specific autoimmunity by H-2^band dose-dependent requirement of H-2^g7for diabetes in NOD mice

The roles of ARID1A in gynecologic cancer

Guillain–Barré syndrome, CIDP and other chronic immune‐mediated neuropathies

EMT, CTCs and CSCs in tumor relapse and drug-resistance

Endometrial cancer: Not your grandmother's cancer

Lack of Estrogen Receptor-α Is Associated with Epithelial–Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer

The long-term prognosis of Guillain-Barré syndrome. Evaluation of prognostic factors including plasma exchange

High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated

GALR1 Methylation in Vaginal Swabs Is Highly Accurate in Identifying Women With Endometrial Cancer

Prognostic Impact of Parity in 493 Uterine Sarcoma Patients

Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer

Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women’s Cancers

ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas

Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients

Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer